TS
ZSPH

Thomas Steyer’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Thomas Steyer’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,000
Closed -$1.05M – 104
2015
Q1 		$1.05M Buy
+25,000
New +$1.14M 0.02% 89

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Thomas Steyer's ZSPH Position: Q2 2015 in Review

Thomas Steyer sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q2 2015, closing a stake of 25,000 shares — an estimated $1.05M sold.

Thomas Steyer first reported a position in ZSPH in Q1 2015 and held it in 1 quarter. The position peaked at $1.05M in Q1 2015. 120 funds tracked by Wall St. Rank hold ZSPH as of Q2 2015.

  • Thomas Steyer reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q2 2015 after selling out during the quarter.
  • Thomas Steyer sold 25,000 ZS PHARMA INC COMS TK (DE) shares in Q2 2015, an estimated $1.05M.
  • Thomas Steyer first reported a position in ZS PHARMA INC COMS TK (DE) in Q1 2015 and held it in 1 quarter.
  • Thomas Steyer's ZS PHARMA INC COMS TK (DE) position peaked at $1.05M in Q1 2015.
  • 120 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q2 2015.

Based on Farallon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.